Abstract-Hypertension is associated with enhanced cardiac sympathetic transmission, although the exact mechanisms underlying this are still unknown. We hypothesized that defective function of the norepinephrine uptake transporter (NET) may contribute to the sympathetic phenotype of the spontaneously hypertensive rat, and that this may occur before the development of hypertension itself. The dynamic kinetics of NET were monitored temporally using a novel fluorescent assay of the transporter in cultured postganglionic sympathetic neurons from the cardiac stellate ganglion, the superior cervical ganglion, the celiac ganglia/superior mesenteric ganglia, and the renal sympathetic chain. All NET activity was blocked by desipramine. NET rate was significantly impaired in cardiac stellate sympathetic neurons from the prehypertensive spontaneously hypertensive rat compared with age-matched normotensive Wistar-Kyoto rats. A similar response was seen in hypertensive spontaneously hypertensive rats stellate sympathetic neurons. However, no reduction in transporter rate was observed at either age in the other major noncardiac sympathetic ganglia. Depolarization of cardiac stellate neurons by electrical field stimulation further potentiated the difference in transporter rate observed between the hypertensive and normotensive rats at both developmental ages. In conclusion, dysregulation of the norepinephrine transporter in the hypertensive rat is ganglion-specific, where NET impairment in the stellate neurons may contribute to the increased cardiac norepinephrine spillover seen in hypertension. 
I
ncreased activity of the sympathetic nervous system is now established as a major contributing factor to the pathophysiology of human hypertension [1] [2] [3] [4] and that observed in the spontaneously hypertensive rat (SHR). [5] [6] [7] [8] [9] However, the exact mechanism underlying sympathetic dysregulation remains unknown, although in both cases hypertension is associated with enhanced cardiac norepinephrine (NE) release. 8, 10, 11 Emerging evidence has shown greater intracellular Ca 2+ transients can facilitate neurotransmission from the cardiac stellate ganglion of the SHR compared with age-matched normotensive controls. 9 However, enhanced transmission may also result from impaired NE reuptake by the norepinephrine uptake transporter (NET; uptake-1) system, although evidence in support of this hypothesis is far from conclusive. 3, [10] [11] [12] [13] In the SHR, NET has been shown to be either downregulated, 12 unaffected, 14, 15 or upregulated. 15, 16 Similarly in human hypertension, the putative role of NET has been reported to be either reduced 3, 10 or unaltered 17 when comparing hypertensive and normotensive subjects. Disparity in results appears to be related to the indirect nature of the different experimental methods used to measure NET and tissues studied. 11, 12, 14, 15 Moreover, measuring the decay or tissue accumulation of administered tritiated NE and its metabolite 3,5-Dihydroxyphenylglycine, in the presence of NET inhibitors, 3, 10, 12 only indirectly assesses NE handling and does not take into account the dynamic kinetics of the neuronal transporter itself.
Using a novel fluorescent assay developed to temporally monitor NET rate within individual sympathetic varicosities of intact tissue preparations, 18 we studied the actual kinetics of NET in 3 distinct populations of isolated sympathetic neurons from the SHR and its age-matched normotensive control. We also investigated the activity of the NET transport system before the development of hypertension itself in addition to its response from animals with established hypertension.
Methods Animals
Age-and weight-matched ( 
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Isolation and Preparation of Sympathetic Postganglionic Neurons
Sympathetic neurons were isolated from the stellate ganglion (which predominately innervates the heart,) superior cervical ganglion (which predominantly innervates the head and neck region) 19 and the celiac ganglion, superior mesenteric ganglion, and sympathetic chain ganglia that innervate the kidneys and other abdominal organs 20,21 from 4-week and 16-week SHR and WKY as previously described. 22 Rats were rendered unconscious using general anesthesia (3% isoflurane and 97% oxygen) then humanely killed by an approved Home Office schedule 1 method: overdose of pentobarbital followed by exsanguination. Sympathetic superior cervical ganglia (SCG), celiac ganglia/ superior mesenteric ganglia (CG/SMG), renal sympathetic chain (RSC), and stellate ganglia were dissected separately and digested using a combination of collagenase and trypsin. To study the effect of NET on renal sympathetic signaling tissue from the CG/SMG was combined with tissue isolated from the area of the sympathetic chain that predominantly innervates the kidneys in 16-week animals only, attributable to the low cell yield when isolating cells from the CG/ SMG only at this age. Dissociated neurons were plated onto poly-D-lysine/laminin substrate coated cover slips (5 mm), placed at 37 o C 5% CO 2 for 1 to 2 days before use. The media used for the isolation and culture of the isolated postganglionic sympathetic neurons were based on modifications of those previously described.
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Immunohistochemistry
See the online-only Data Supplement.
Measurement of Norepinephrine Uptake Rate
Protocol
Twelve groups of cells were studied: young SHR prehypertensive cardiac stellate, SCG, and CG/SMG cells with age-matched control WKY cardiac stellate and SCG cells; adult cardiac stellate, SCG, and CG/SMG/ RSC cells from hypertensive SHR and its age-matched WKY controls.
A control period of 5 minutes in Tyrode solution was followed by a 5-minute perfusion with buffer containing 1:10 concentration of the neurotransmitter transporter uptake assay (NTUA) (consistent with concentrations used in previous studies). 18 The perfusion system was then stopped (to prevent any change in fluorescence attributable to cell drift) and cells held stationary in the NTUA-containing buffer 37±0.5 o C for 10 minutes, where the rate of increase in fluorescence within the cell was recorded. To confirm the specificity of the assay to NET, the NET inhibitor 24 desipramine (DMI 1 μmol/L) was added to the perfusing Tyrode at 20 minutes. At 35 minutes, cells were reperfused with NTUA (1:10) + DMI (1 μmol/L) and the hold protocol repeated from 40 to 50 minutes. Any cell in which the increase in fluorescence was not blocked by DMI was excluded from analysis as any previous rate of uptake of the assay could not be confirmed to be NET specific.
The rate of increase in intracellular fluorescence was recorded by selecting a region of interest around the isolated postganglionic cell. Images were acquired every 2 seconds using a photometrics CoolSNAP HQ 2 camera, excitation wave length 440 nm, emissions band 535±35 nm.
Results were presented as increase in fluorescence over time, normalized to the starting intracellular fluorescence of the cell at t=10 
Electrical Field Stimulation of Isolated Sympathetic Postganglionic Neurons
Cell depolarization was induced by electrical field stimulation (EFS) (5 Hz, 10 V, 10 ms, 2.5 min) by a pair of parallel horizontal platinum electrodes mounted within the perfusion chamber. Parameters were chosen to match stimulation frequency and rate, which shows submaximal noradrenaline release to right cardiac stellate stimulation in the isolated double atria preparation.
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Measurement of NET Rate in Isolated Sympathetic Neurons
Cultured cells were confirmed to be sympathetic specific by positive immunoreactivity to anti-tyrosine hydroxylase labeling in all cell types ( Figure 1 ). There was a linear increase in intracellular fluorescence when cells were incubated in a solution containing the assay ( Figure 2 ). The rate of increase in fluorescence within the neuronal cell was monitored over time, and the gradient of the slope (y=mx+c) was normalized to the initial fluorescence. DMI consistently blocked the action of NET fluorescence in all cells.
Neuronal NE Reuptake Is Decreased in Cardiac Stellate Neurons From the Prehypertensive SHR
Cardiac stellate neurons from 4-week-old prehypertensive SHR rats demonstrated a significant reduction in NET rate (3.21±0.24 au/min, n=24) compared with age-matched WKY rats (4.21±0.40 au/min, n=21, P<0.05, unpaired t test; Figures 3A, 3B, and 5A. However, there was no difference in uptake rate in sympathetic neuronal cells isolated from the SCG of 4-week SHR (n=49) or WKY rats (n=52), nor neurons isolated from the CG/SMG of 4-week SHR (n=15) or WKY (n=18; Figure 3C -3F).
Neuronal NE Reuptake Is Decreased in Cardiac Stellate Neurons From Hypertensive SHR Compared With WKY Rats
Like the response from prehypertensive cells, the NET transporter was significantly reduced in cardiac stellate neurons of hypertensive SHR rats (2.82±0.25 au/min, n=20) compared with age-matched normotensive WKY rats (3.69±0.33 au/min, n=19, P<0.05, unpaired t test; Figures  4A, 4B, and 5B). Moreover, no difference in uptake rate was observed between sympathetic neuronal cells isolated from the SCG in SHR (n=24) or WKY (n=24), nor cells isolated from the CG/SMG/RSC of SHR (n=18) or WKY (n=23; Figure 4C-4F) . DMI blocked the action of the NET fluorescence in both groups of neurons. 
Effect of Cell Depolarization on NE Uptake Rate in Cardiac Stellate Neurons
To test whether the level of neuronal excitability contributed to the difference between cardiac stellate SHR versus WKY cells, preparations were depolarized by EFS. This evoked a significant increase in NET transporter activity at both developmental ages of WKY rats compared with age-matched SHRs (% uptake rate with EFS compared with control, SHR 4W: 99.19±4.12 %, n=24, WKY 4W 112.7±5.32 %, n=21, P<0.01, unpaired t test. SHR 16W: 91.53±6.41 %, n=20, WKY 16W 112.5±6.02 %, n=19, P<0.01, unpaired t test; Figure 6 ). The increase in transporter rate observed in both ages of WKY was significantly greater during EFS compared with no stimulation (4W WKY n=21, P<0.05; 16W WKY n=19, P<0.05; paired t test). However, NET rate still remained impaired in the SHR during depolarization (4W SHR n=24, P=0.87; 16W SHR n=20; P=0.20).
Cells Isolated From the CG/SMG and the Renal Innervations of the Sympathetic Chain
Because of the morphology of the sympathetic renal innervations, the CG and SMG could not be identified and isolated as separate sympathetic ganglia. 20, 21 Therefore, both ganglia were removed and dissociated for cell isolation. To increase cell yield from the 16-week animals, neurons were isolated from both the CG/SMG and the area of the sympathetic chain 21 RSC posterior to the kidneys, which innervates the renal area and other abdominal organs. CG/SMG and RSC cells were cultured and tested separately, no difference in neuronal NE reuptake rate was observed between CG/SMG or RSC neurons of either 16W SHR (CG/SMG n=7, RSC n=11, P=0.51, paired t test) or 16W WKY (CG/SMG n=12, RSC n=11, P=0.49, paired t test).
Effect of Age on Neuronal NE Uptake in Sympathetic Ganglia
NET rate in cardiac stellate neurons (SHR P=0.27, WKY P=0.33) and CG/SMG/RSC neurons (SHR P=0.30, WKY P=0.41) was unaltered between age groups of the same strain ( Figure 5 ). Although, in superior cervical ganglion neurons, increased age was associated with a significant reduction in NET rate in both strains (SHR, P<0.0001, unpaired t test; WKY, P<0.0001, unpaired t test). This suggests a possible role of age that might contribute to defective NET activity previously implied from human 25, 26 and rodent studies. the hypothesis that a reduction in NET in the SHR contributes to the increased cardiac norepinephrine spillover observed in hypertension, and that the NET response during sympathetic activation appears to be ganglion-specific in the SHR.
NET Activity in 3 Different Sympathetic Ganglia in the SHR
Hypertension is a multiorgan disease that primarily involves impairment of the kidney, vasculature, and autonomic nervous system. 4, 28 Increased activity in the sympathetic nervous system has been widely implicated in hypertension, [1] [2] [3] [4] and it is conceivable that a part of this response is related to impaired NET activity, resulting in increased junctional NE concentrations. 3, 10, [12] [13] [14] [15] Studies investigating defective NET activity in hypertension have been inconclusive. We observed that stellate sympathetic neurons had a significant reduction in NET activity in the SHR compared with WKY; however, no difference in NET rate was observed when comparing age-matched SHR and WKY cells isolated from the SCG or the CG/SMG. This implies that there is a significant heterogeneity of response within the sympathetic nervous system in the SHR that may contribute to the disparity in results previously reported. Moreover, care should be taken when applying results from different sympathetic ganglia and using these to support or refute a global role for NET dysregulation in hypertension.
Increased sympathetic activity has also been reported to increase with age in patients with hypertension 25, 26 and in rat models 27 of hypertension. Although we saw no difference in NET activity between age-matched SHR and WKY SCG sympathetic neurons, a significant reduction in activity with age was observed between both groups of rats and both ganglia. This suggests the aging process itself is a further modulating factor in the development of the neural phenotype, as has been previously suggested in human 1, 29 and rodent studies. 6 It is also possible that our NET assay might have an affinity for other monoamine transporters. However, there is no compelling data supporting significant expression of other transporters in the ganglia we studied. 30 Moreover, DMI is a potent inhibitor of NET with a K i of 4 nmol/L compared with the serotonin transporter (K i = 61 nmol/L: Sigma data sheet product code D3900).
Effect of Neuronal Activation on Cardiac Stellate Sympathetic NET Activity in the SHR and WKY
Increased sympathetic nerve firing 29 and increased NE spillover 10 are associated with clinical hypertension. Depolarization induced intracellular calcium transients are also greater in isolated cardiac stellate neurons from the SHR compared with the WKY rats. 9 Interestingly the enhanced [Ca 2+ ] i response was also seen in prehypertensive SHR. 9 The mechanism underpinning the enhanced [Ca 2+ ] i 9 that results in facilitated neurotransmission 8 appears to be related to impaired mitochondrial Ca 2+ uptake and release in the SHR. A, Norepinephrine uptake transporter (NET) action was significantly decreased in the 4-wk spontaneously hypertensive rats (SHR) stellate neurons compared with Wistar-Kyoto rats (WKY; SHR n=24, WKY n=21; *P<0.05, unpaired t test). There was no significant difference in uptake rate between superior cervical ganglia (SCG) cells of the SHR (n=49) and WKY (n=52), nor celiac ganglia/superior mesenteric ganglia (CG/ SMG) cells of the SHR (n=15) and WKY (n=18). B, NET action was significantly decreased in 16-wk SHR stellate neurons compared with WKY (WKY n=19, SHR n=20; *P<0.05, unpaired t test), but not within SCG neurons (SHR n=24, WKY n=24), nor CG/SMG/ renal sympathetic chain (RSC) cells of the SHR (n=18) and WKY (n=23). Cell depolarization has been linked to an increase in transporter function; however, this does not appear to be dependent on membrane potential but is linked to Ca 2+ activation of intracellular kinases. 31 EFS that triggered cell depolarization was observed to further augment the difference in NET transporter rate between cardiac stellate neurons from SHR and WKY rats. Although the mechanism is poorly understood, neuronal depolarization may provide positive feedback to upregulate NET transporter activity in neurons from the WKY. No such effect on activity was observed in the SHR that suggests defective signaling. Moreover, basal NET expression measured using Western blot was not different between SHR and WKY rats, 32 suggesting intracellular pathways coupled to NET are dysregulated in the SHR.
Molecular Modulation of NET in the SHR
The NET transporter along with other major monoamine transporters belongs to the Na + /Cl − -dependent transporter super family, 33, 34 requiring the binding of both Na + and Cl − for NE binding and transport. The coupling stoichiometry is predicted to be 1 NE:1 Na + :1 Cl − resulting in 1 net inward positive charge per cycle, with increased NE uptake being observed at negative potentials. 35 The molecular mechanism underpinning defective NET signaling in the cardiac stellate is not known but could conceivably be related to changes at the level of transcription, translation, or posttranslation modification.
Extensive study of the NET protein-gene sequence has revealed several regulatory domains and consensus sites for protein kinases and phosphatases. NET activity is reduced by activation of a number of protein kinases. Specifically, protein kinase C, which facilitates transporter internalization, 36 and Ca
2+
calmodulin-activated kinase II, which is linked to changes in receptor catalytic activity without altering surface expression, 31 are both possible candidates. In addition, phosphatidylinositol 3-OH kinase can enhance NET transport by supporting the phosphorylation to p38 MAPK (mitogen-activated protein kinase). 37 Similarly Mas receptor stimulation can upregulate NET via Akt and Erk1/2-dependent pathways in the SHR as a potential compensation pathway to maintain appropriate NE levels. 32 Regulation of transporter function by interaction of components of the vesicle release SNARE complex (predominantly syntaxin-1A) and NET have also been observed, 38, 39 revealing a Ca 2+ -dependent NET regulation by a protein kinase C-dependent, calmodulin-activated kinase independent mechanism. This results in both an increase in surface trafficking of NET, but also a direct interaction that acts to limit NET catalytic function. 38, 39 When these studies are viewed together they highlight the complexity of the NET reuptake pathways, because NET dysregulation in the SHR could be residing at several intracellular sites.
Perspectives
The results from this study show that differences in NET activity between cardiac stellate sympathetic neurons of SHR and WKY rats occur early in the development of hypertension and before the onset of high blood pressure. The overall translational significance of these observations and the molecular mechanisms underpinning them are yet to be established. NET acts to terminate the action of NE by sequestration of junctional NE back into the sympathetic nerve terminal. The present study combined with preexisting data provides strong evidence that faulty NET activity within stellate sympathetic neurons of the SHR is a contributing factor to the increase in cardiac sympathetic responsiveness and postneuronal NE concentrations previously observed in the SHR and in clinical hypertensives. 3, 10, 12 The observation that this difference was not seen in other major noncardiac sympathetic ganglia provides evidence for tissue heterogeneity within cellular signaling of autonomic neurons. Targeting of NET in hypertension could be therapeutically beneficial; however, it is important to note that sympathetic impairment occurs at several sites in the cardiac-neural axis. 7, 8, 40 What Is New?
• The first dynamic study of norepinephrine uptake transporter (NET) rate in isolated sympathetic neuronal cells from the heart, vasculature, and kidney in the spontaneously hypertensive rats / Wistar-Kyoto rats using a novel fluorescent compound.
What Is Relevant?
• Dysregulation of the cardiac branch of the sympathetic autonomic nervous system occurs not only in developed hypertension but also in the prehypertensive state.
• Reduced NE reuptake by NET contributes to this cardiac stellate sympathetic phenotype observed in hypertension and may therefore be a therapeutic target.
Summary
A novel imaging technique has been used to dynamically study NET activity in neuronal cells isolated from 3 major sympathetic ganglia previously implicated in hypertension. NET activity was found to be downregulated in cardiac stellate neurons of spontaneously hypertensive rats rats at both 4-week prehypertensive and 16-week hypertensive age compared with Wistar-Kyoto controls. However, no difference in NET activity was observed in superior cervical ganglia or renal ganglia at either developmental age of spontaneously hypertensive rats compared with Wistar-Kyoto rats, indicating that defective NET activity does not contribute to the increased sympathetic signaling within these tissues.
